RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $672,711 | +258.1% | 29,344 | +157.6% | 0.01% | +250.0% |
| Q2 2023 | $187,871 | +40564.7% | 11,393 | -56.0% | 0.00% | -71.4% |
| Q1 2023 | $462 | -100.0% | 25,874 | -69.1% | 0.01% | -84.1% |
| Q3 2022 | $2,053,000 | +294.8% | 83,796 | -33.2% | 0.04% | +214.3% |
| Q2 2022 | $520,000 | -11.9% | 125,416 | +144.8% | 0.01% | 0.0% |
| Q1 2022 | $590,000 | +100.7% | 51,238 | +73.8% | 0.01% | +180.0% |
| Q4 2021 | $294,000 | -79.3% | 29,478 | -55.9% | 0.01% | -82.8% |
| Q1 2021 | $1,422,000 | +485.2% | 66,852 | +761.7% | 0.03% | +262.5% |
| Q2 2018 | $243,000 | – | 7,758 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |